Gilgamesh Pharmaceuticals Is A Clinical Stage Biotechnology Company Based In New Yorkfounded In 2019The Company Focuses On Developing Innovative Therapeutics For Mental Health Disordersaiming To Create Rapid Acting Treatments That Address The Root Causes Of Conditions Such As Depressionanxietyand Opioid Use Disorderwith A Team Of 15 Employeesgilgamesh Is Part Of Y Combinatorae S S20 Batch The Company Specializes In New Chemical Entitiesncesthat Leverage The Therapeutic Potential Of Psychedelics While Minimizing Side Effectstheir Compounds Are Designed For Rapid Efficacyoptimized Treatment Durationimproved Safety Profilesand Non Hallucinogenic Optionsgilgamesh Utilizes An Ai Driven Discovery Platform That Integrates Behavioral Analysis And Molecular Neuroplasticity Measurements To Enhance Drug Optimizationthey Collaborate With Pharmaceutical Partnersresearch Institutionsand Healthcare Providers To Advance Their Mission Of Providing Effective Alternatives For Treatment Resistant Mental Health Conditions
